To further explore the role of CHI3L1 protein in the CHI3L1-AP-1-MMP pathway, cancer cells were treated with ERK inhibitor (U0126) or JNK inhibitor (SP600125), followed by the addition of CHI3L1 protein in MKN-45 and MDA-MB-231 cells. Here, MAPK8 is linked to cancer.